
Stock Market Surge as Tech Titans Power Record Highs for S&P 500 and Nasdaq
Microsoft’s cloud surge and Meta’s upbeat guidance fuel a narrow rally even as cyclicals and select sectors lag | That's TradingNEWS
Broad Market Indices Forge New Highs Amid Tech-Led Leadership
The S&P 500 (^GSPC) extended its July advance to +3.1%, trading up 0.4% mid‐morning at 6,372.02, a fresh intraday peak. The Nasdaq Composite (^IXIC) outperformed, rising 0.7% to 21,229.54, lifting its July gain to roughly +5.0%. By contrast, the Dow Jones Industrial Average (^DJI) eked out just a 0.1% increase, reflecting underperformance of industrial and financial names relative to mega-cap tech. Market breadth remains narrow: just 35% of S&P 500 components trade above their 50-day moving average, underscoring heavy concentration in a handful of AI and cloud leaders.
Mega-Cap Tech Titans: Cloud & AI Fuels Billion-Dollar Rallies
-
Microsoft (MSFT) vaulted 6.0%, adding $305 billion in market value, after posting $3.65 EPS vs. $3.37 expected and announcing Azure annual revenue topped $75 billion—up 58% YoY. Its $535.88 share price now reflects a $4.1 trillion market cap.
-
Meta Platforms (META) soared 11.5%, buoyed by Q2 revenue of $37.0 billion (+23% YoY) vs. $35.5 billion consensus, and guidance for Q3 sales of $47.5–$50.5 billion vs. $46.2 billion street estimate. Reality Labs losses narrowed to $4.2 billion from $5.9 billion, suggesting improving AI R&D efficiency.
-
Nvidia (NVDA) remains perched at the top, trading near $460 with a $4.4 trillion capitalization after earlier this month joining Microsoft in the exclusive $4 trillion club.
Infrastructure & Cloud Capex: Select Names Riding the Upswing
-
CoreWeave (CRWV) shares jumped 12.2% to $115.47, reflecting its 72% revenue exposure to hyperscale cloud clients, chiefly Microsoft. With MSFT capex at $88.2 billion in FY 2025, up from $56 billion the prior year, CoreWeave is well-positioned for continued demand in AI compute.
-
Oracle (ORCL) up 2.4% today, is another prime beneficiary as enterprises ramp on-prem Exadata deployments alongside Oracle Cloud Infrastructure (+44% YoY).
Consumer & Retail: Divergence Between Credit-Fueled & Value-Driven Players
-
Carvana (CVNA) exploded 17.7% premarket to $392.75 after reporting record Q2 net income of $308 million ($1.28 EPS vs. $0.85 consensus) on $6.94 billion revenue (+42% YoY), though $274 million of profit derived from loan-sale gains.
-
eBay (EBAY) jumped 18.6% to $92.03, raising Q3 revenue guidance to $2.69–$2.74 billion vs. $2.65 billion expected on resilient demand for refurbished and used goods.
-
Kellanova (K) fell 0.2% after missing Q2 adjusted EPS of $0.93 vs. $0.99 est., with $3.20 billion in sales inline but demand softness in snacks/ready-to-eat across North America.
-
“Meme” names Kohl’s (KSS), Krispy Kreme (DNUT) and GoPro (GPRO) have cratered 88%, 84% and 65% respectively from their mid-July peaks, as retail traders rotate back to Big Tech.
Healthcare & Biotech: Growth Versus Margin Pressures
-
Align Technology (ALGN) plunged 34.0% to $134.30 on a Morgan Stanley downgrade to Equal Weight and Q2 miss: $2.49 EPS vs. $2.57 est., $1.01 billion revenue vs. $1.06 billion expected, casting doubts on Invisalign growth trajectory.
-
Moderna (MRNA) announced a 10% workforce reduction by end-2025 amid slowing Covid-shot sales; shares down 3.1%.
-
Bristol-Myers Squibb (BMY) beat with $12.3 billion revenue (+1% YoY) vs. $11.4 billion consensus and $1.46 EPS vs. $1.07 est., driven by Eliquis (+8% to $3.7 billion) and Opdivo (+7% to $2.6 billion); Revlimid fell 38% to $838 million.
-
CVS Health (CVS) rose 2.8% after Q2 EPS of $1.81 vs. $1.46 est. on $98.9 billion revenue (+8.4%), lifting FY 2025 revenue forecast to $139 billion from $138 billion.
Financial Services & Payments: Credit Card Resilience
-
Mastercard (MA) delivered $8.1 billion revenue (+17% YoY) vs. $7.97 billion est. and $4.15 EPS vs. $4.03 est., with cross-border volume +15%—a strong signal of global travel and discretionary spending recovery. Shares up 1.9%.
-
American Express (AXP) climbed 1.2% after reporting 18% YoY growth in billed business in Q2, underscoring consumer credit strength.
-
Qualcomm (QCOM) underperformed, down 5.9% premarket, as handset revenue guidance of +5% QoQ in Q3 lacked the datacenter upside investors crave.
Fixed Income & FX: Yields Near Multi-Year Highs
-
The U.S. 2-year Treasury yield hit 4.97%, while the 10-year stood at 4.12%, flattening the curve to just −0.85 ppt, a level historically tied to recession warnings.
-
The U.S. Dollar Index (DXY) sits at 103.5, up 0.4% as safe-haven flows bolster the greenback. EUR/USD trades near 1.095, weighed by softer Eurozone PMI data.
Commodities & Volatility: Oil, Gold & VIX Signals
-
WTI crude oil trades at $80.50/bbl (+0.3%), supported by OPEC+ supply discipline and robust U.S. driving season demand.
-
Gold is bid at $1,920/oz (+0.2%), with real rates still elevated but geopolitical jitters capping downside.
-
The CBOE Volatility Index (VIX) dipped to 13.4, indicating complacency even as valuation multiples on mega-caps surge.
Global Markets Snapshot: Asia Under Pressure, Europe Mixed
-
Asia–Pacific: Hong Kong’s Hang Seng dropped 1.51%, CSI 300 slid 1.82%, South Korea’s Kospi down 0.28% while the Kosdaq gained 0.20%. Japan’s Nikkei +0.50%, buoyed by a weaker yen at ¥145/USD.
-
Europe: FTSE 100 +0.20%, Germany’s DAX +0.10%, France’s CAC 40 +0.15% as investors digest mixed earnings and looming EU–U.S. trade talks.
Insider Transactions & Sentiment Signals
According to Refinitiv data, S&P 500 insider selling totaled $2.3 billion in July, almost double the $1.2 billion in purchases, suggesting corporate insiders are taking chips off the table even as the index nears all-time highs. Notably, several meg‐caps reported modest insider buybacks, but overall net sales indicate prudent caution from executives.
Macro Crosscurrents: Fed, Inflation & Trade Uncertainty
-
June’s Personal Consumption Expenditures (PCE) index showed headline inflation at +2.6% YoY and core at +2.8%, each 0.1 ppt above consensus, reinforcing that tariffs and supply-chain bottlenecks continue to feed price pressures.
-
The Federal Reserve held the funds rate at 5.25–5.50%, with two governors dissenting for a 25 bp cut—the first dual dissent since 1993. Chair Powell stressed it’s “early days” to assess full tariff impacts, and market odds for a September rate cut have fallen from 60% to 40%.
-
Treasury Secretary Scott Bessent said U.S.–China trade talks have “the makings of a deal” ahead of an Aug. 1 tariff truce deadline, though details remain scant. Concurrently, a U.S.–South Korea accord imposes a 15% Korean export tariff in exchange for zero duties on U.S. goods and $350 billion in Korean investment.
Strategist Perspectives: Valuations Versus Fundamentals
-
Joseph Cusick (Calamos Research) warns of a potential “blow-off top,” noting “strong earnings, capex, and buybacks are priced into sky-high valuations with scant margin for error,” even as downside moves have been contained.
-
David Russell (TradeStation) cautions that “tariff and seasonality headwinds may erode the market’s ‘glass-half-full’ bias,” particularly if secondary sanctions on Russian oil buyers intensify.
Upcoming Catalysts to Watch
-
Earnings: Apple (AAPL), Amazon (AMZN), Bristol-Myers (BMY), Procter & Gamble (PG), Ford (F) report next week—expect volatility around forward guidance.
-
Economic Data: July CPI on Aug. 13; global PMIs Aug. 5; Jackson Hole Symposium Aug. 21–23 could reset Fed expectations.
-
Fiscal & Geo: U.S. tariffs activation Aug. 1 if trade terms with China are not finalized; appeals court deliberation on Trump’s 1977 IEEPA tariff authority likely in early August.
Top Tactical Recommendations
Ticker | Rating | Target | Rationale |
---|---|---|---|
MSFT | Buy | $580 | Unrivaled cloud & AI execution; multiple expansion justified by 58% capex growth. |
META | Buy | $860 | Ad spend strength; Reality Labs loss reduction; Q3 guide well above consensus. |
NVDA | Hold | $480 | Premium valuation; monitor datacenter adoption vs. supply constraints. |
AAPL | Hold | $198 | Await Q3 results; iPhone cycle maturity balanced by services growth. |
AMZN | Hold | $180 | AWS robust but margin pressure in retail persists; buyback support. |
CRWV | Buy | $135 | Direct lever to hyperscale AI spend; 72% top-line dependency on MSFT & META. |
ALGN | Sell | $120 | Guidance cut and downgrades signal eroded growth visibility in dental market. |
EBAY | Buy | $105 | Raised guidance; secular tailwinds in value retail; low multiple vs. peers. |
BMY | Hold | $50 | Blockbusters cushion patent cliffs; monitor Revlimid decline trajectory. |
CVS | Buy | $70 | Integrated model gaining traction; beats on multiple fronts; sticky PBM margins. |
MA | Buy | $460 | Cross-border rebound; secular shift to digital payments; strong EPS leverage. |
QCOM | Hold | $155 | Handset resilience offset by delayed data center catalysis; valuation peak. |
RBLX | Buy | $165 | 41% DAU growth to 111 million; bookings guide ahead; engagement +58% YoY. |
Position tactically in high-conviction cloud/AI themes while trimming exposure to cyclical and over-extended retail/meme-stock plays.